BIOMAT Database Logo BIOMAT Database Logo

Synthesis of pro-apoptotic indapamide derivatives as anticancer agents. 2015

Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
a TUBITAK Marmara Research Center, Materials Institute Gebze , Kocaeli , Turkey .

4-Chloro-3-({[(substitutedamino)carbonothioyl]amino}sulfonyl)-N-(2-methyl-2,3-dihydro-1H-indole-1-yl)benzamide (1-20) and 4-chloro-3-({[3-(substituted)-4-oxo-1,3-thiazolidine-2-ylidene]amino}sulfonyl)-N-(2-methyl-2,3-dihydro-1H-indole-1-yl)benzamide derivatives (21-31) were synthesized from 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide (indapamide). 4-Chloro-3-({[(4-chlorophenyl) amino) carbonothioyl]amino}sulfonyl)-N-(2-methyl-2,3-dihydro-1H-indole-1-yl)benzamide 12 demonstrated the highest proapoptotic activity among all synthesized compounds on melanoma cell lines MDA-MB-435 with 3.7% growth inhibition at the concentration of 10 µM. Compound 12 (SGK 266) was evaluated in vitro using the MTT colorimetric method against melanoma cancer cell line MDA-MB435 growth inhibition for different doses and exhibited anticancer activity with IC50 values of 85-95 µM against melanoma cancer cell line MDA-MB435. In addition, this compound was investigated as inhibitors of four physiologically relevant human carbonic anhydrase isoforms, hCA I, II, IX and XII. The compund inhibited these enzymes with IC50 values ranging between 0.72 and 1.60 µM.

UI MeSH Term Description Entries
D007190 Indapamide A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. Metindamide,S-1520,SE-1520,S 1520,S1520,SE 1520,SE1520
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002256 Carbonic Anhydrases A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1. Carbonate Dehydratase,Carbonic Anhydrase,Anhydrases, Carbonic,Dehydratase, Carbonate
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D003124 Colorimetry Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Small molecules as pro-apoptotic anticancer agents.
September 2012, Pharmaceutical patent analyst,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
March 2019, Molecules (Basel, Switzerland),
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents.
May 2013, Archiv der Pharmazie,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Novel thiazolidine derivatives as potent selective pro-apoptotic agents.
September 2021, Bioorganic chemistry,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.
March 2012, Bioorganic & medicinal chemistry letters,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Azafuramidines as potential anticancer Agents: Pro-apoptotic profile and cell cycle arrest.
January 2024, Bioorganic & medicinal chemistry letters,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Synthesis, antiproliferative and apoptotic activities of N-(6(4)-indazolyl)-benzenesulfonamide derivatives as potential anticancer agents.
November 2012, European journal of medicinal chemistry,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Design and synthesis of celastrol derivatives as anticancer agents.
May 2015, European journal of medicinal chemistry,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents.
February 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Özgür Yılmaz, and Suna Özbaş Turan, and Jülide Akbuğa, and Pınar Mega Tiber, and Oya Orun, and Claudiu T Supuran, and Ş Güniz Küçükgüzel
Synthesis of 13-amino costunolide derivatives as anticancer agents.
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!